travoprost

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 157283-68-6

Where It Comes From

26 FDA-registered drug labelers
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Limited
Apotex Corp.
Bryant Ranch Prepack
Cayman Pharma s.r.o.
Chirogate International Inc
DR REDDYS LABORATORIES (EU) LTD
EUROAPI Hungary Ltd.
Everlight Chemical Industrial Corporation Kuanyin II Plant
Gland Pharma Limited
Glaukos Corporation
GLENMARK PHARMACEUTICALS INC
Golden State Medical Supply, Inc.
Industriale Chimica s.r.l.
Micro Labs Limited
MSN Laboratories Private Limited
Mylan Pharmaceuticals Inc.
NEWCHEM SPA
Novartis Pharmaceuticals Corporation
Sagent Pharmaceuticals
Sandoz Inc
ScinoPharm Taiwan Ltd.
Siegfried Grafton, Inc.
Somerset Therapeutics, LLC
Synergy Health AST, LLC
YS Life Science Co., Ltd.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 8 drug and cosmetic product listings (FDA).

  • Travoprost Ophthalmic Solution, 0.004%
  • Travoprost Ophthalmic
  • Travoprost
  • Travoprost ophthalmic solution
  • Travoprost Ophthalmic Soluton
  • iDose TR
  • Travoprost Ophthalmic Solution USP, 0.004% Travoprost
  • Travatan Z
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS157283-68-6
PubChem CID5282226
DTXSIDDTXSID80896948
FormulaC26H35F3O6
Mol. Weight500.5 g/mol
SMILESCC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O

Data Sources

52822262026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/travoprost/cids/JSON

Archive: data/sources/pubchem_name/travoprost.json

CAS 157283-68-62026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

bulk match2026-04-07

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json